Catherine Bladen, PhD, is chief scientific officer, Vector Laboratories. Catherine leads the technical development and innovation team at Vector Laboratories, Inc. She has more than 25 years of experience in biochemistry research (specifically protein identification, purification, and characterization) both in the UK and the USA. She completed her PhD in 2001 in the Cancer Research Unit at Newcastle University, studying novel proteins involved in p53 independent cancer pathways.